WILLEM OVERWIJK to Adjuvants, Immunologic
This is a "connection" page, showing publications WILLEM OVERWIJK has written about Adjuvants, Immunologic.
Connection Strength
0.455
-
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant. J Immunol. 2006 May 01; 176(9):5213-22.
Score: 0.204
-
Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+ T Cell Response. J Immunol. 2018 05 15; 200(10):3464-3474.
Score: 0.116
-
Cancer vaccines in the era of checkpoint blockade: the magic is in the adjuvant. Curr Opin Immunol. 2017 Aug; 47:103-109.
Score: 0.111
-
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy. Vaccine. 2009 May 26; 27(25-26):3484-8.
Score: 0.015
-
Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responses. J Interferon Cytokine Res. 2000 Jun; 20(6):589-96.
Score: 0.008